ACE2 and COVID-19: Although the association between ACE2 expression and the disease severity in COVID-19 patients is still not well understood, it is possible that high ACE2 expression in smokers might play a role in the adverse outcome observed among this population by either direct epithelial cell damage or through downstream events of the inflammatory cascade.